Despite extensive knowledge of metabolic pathways, understanding the basic metabolic mechanisms of prominent diseases is limited by the ability to grasp the regulation of complex metabolic systems. Genetic gain/loss of function approaches have provided a wealth of information about how metabolism can be regulated, but have not been very successful at identifying the cause of complex disease. Ideally, top-down approaches would be used to examine the function of metabolism using quantitative approaches, then to guide gain/loss of function studies. The scientific community is moving quickly to stable isotopes because of high information yield, convenience, and the capacity to translate methods between human subjects, rodent models and cell preparations. To accomplish this goal, it is essential to extend earlier concepts using computational methods, and to integrate mass spectrometry (MS) with nuclear magnetic resonance (NMR). However, in order for the approaches to be embraced by the molecular physiologist/geneticist or clinical scientist interested in disease physiology, they must be flexible, reliable and easy-to-use methods relevant in a wide range of conditions. In this TR&D project we will perform cell, rodent and computational studies to develop translation methods to address these needs. First, we will integrate tracer flux approaches and metabolomics to identify target enzymes in the regulation of metabolism or its dysregulation during disease. Secondly, we will leverage the specificity of NMR isotopomer analysis and the sensitivity of mass isotopomer analysis to measure flux with high confidence on milligram scale samples. Finally, we will develop and distribute a free, open source software platform that simulates NMR and MS data based on flux/tracer input and calculates flux from experimental data in a single, easy to use graphical interface complete. Accomplishing these aims will provide the scientific community with new tools that will guide tactical studies in pharmacology, genetics and clinical science.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Biotechnology Resource Grants (P41)
Project #
5P41EB015908-31
Application #
9623351
Study Section
Special Emphasis Panel (ZEB1)
Project Start
Project End
Budget Start
2019-01-01
Budget End
2019-12-31
Support Year
31
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Wu, Cheng-Yang; Satapati, Santhosh; Gui, Wenjun et al. (2018) A novel inhibitor of pyruvate dehydrogenase kinase stimulates myocardial carbohydrate oxidation in diet-induced obesity. J Biol Chem 293:9604-9613
Ren, Jimin; Shang, Ty; Sherry, A Dean et al. (2018) Unveiling a hidden 31 P signal coresonating with extracellular inorganic phosphate by outer-volume-suppression and localized 31 P MRS in the human brain at 7T. Magn Reson Med 80:1289-1297
Burnett, Marianne E; Adebesin, Bukola; Ratnakar, S James et al. (2018) Crystallographic Characterization and Non-Innocent Redox Activity of the Glycine Modified DOTA Scaffold and Its Impact on EuIII Electrochemistry. Eur J Inorg Chem 2018:1556-1562
Cui, Jiaming; Dimitrov, Ivan E; Cheshkov, Sergey et al. (2018) An Adjustable-Length Dipole Using Forced-Current Excitation for 7T MR. IEEE Trans Biomed Eng 65:2259-2266
Sirusi, Ali A; Suh, Eul Hyun; Kovacs, Zoltan et al. (2018) The effect of Ho3+ doping on 13C dynamic nuclear polarization at 5 T. Phys Chem Chem Phys 20:728-731
Courtney, Kevin D; Bezwada, Divya; Mashimo, Tomoyuki et al. (2018) Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo. Cell Metab 28:793-800.e2
Potts, Austin; Uchida, Aki; Deja, Stanislaw et al. (2018) Cytosolic phosphoenolpyruvate carboxykinase as a cataplerotic pathway in the small intestine. Am J Physiol Gastrointest Liver Physiol 315:G249-G258
Wu, Cheng-Yang; Tso, Shih-Chia; Chuang, Jacinta L et al. (2018) Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice. Mol Metab 12:12-24
Jin, Eunsook S; Browning, Jeffrey D; Murphy, Rebecca E et al. (2018) Fatty liver disrupts glycerol metabolism in gluconeogenic and lipogenic pathways in humans. J Lipid Res 59:1685-1694
Makarewich, Catherine A; Baskin, Kedryn K; Munir, Amir Z et al. (2018) MOXI Is a Mitochondrial Micropeptide That Enhances Fatty Acid ?-Oxidation. Cell Rep 23:3701-3709

Showing the most recent 10 out of 149 publications